Hospital São Vicente de Paulo

Passo Fundo, Rio Grande do Sul 99010-090

0 studies enrolling now · 9 studies all time

What they study most

Adjuvant, Breast Cancer, COVID-19, Deep Vein Thrombosis (DVT), Diabetes Mellitus, Type 2, Dyslipidemia, EGFR, Early Stage Lung Cancer, Exon 20, First Line Non-Small Cell Lung Cancer, Lung Cancer, NSCLC, Stage IB-IIIA

Studies at this site

• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial — Completed
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Dapagliflozin in Respiratory Failure in Patients With COVID-19 — Completed